Title:
ANTI-HUMAN PD-L1 HUMANIZED MONOCLONAL ANTIBODY AND APPLICATION THEREOF
Document Type and Number:
WIPO Patent Application WO/2017/197667
Kind Code:
A1
Abstract:
Provided are an anti-human PD-L1 humanized monoclonal antibody and an application thereof. The antibody can specifically binds to human PD-L1, and can bind to activated T cells to enhance the activation effect of the T cells, thereby having significant inhibiting effects on tumor growth.
Inventors:
ZHU YIXIANG (CN)
GUO SHUHUA (CN)
ZHANG JIACHUN (CN)
LI GE (CN)
GUO SHUHUA (CN)
ZHANG JIACHUN (CN)
LI GE (CN)
Application Number:
PCT/CN2016/084643
Publication Date:
November 23, 2017
Filing Date:
June 03, 2016
Export Citation:
Assignee:
REYOUNG (SUZHOU) BIOLOGY SCIENCE & TECH CO LTD (CN)
International Classes:
A61K39/395; C07K16/28; A61P35/00; C12N15/13
Domestic Patent References:
| WO2016061142A1 | 2016-04-21 | |||
| WO2016022630A1 | 2016-02-11 |
Foreign References:
| CN104994873A | 2015-10-21 | |||
| US20140044738A1 | 2014-02-13 |
Other References:
See also references of EP 3459973A4
Attorney, Agent or Firm:
BEIJING TONGHUI INTELLECTUAL PROPERTY OFFICE (GENERAL PARTNERSHIP) (CN)
Download PDF: